Intra-Cellular Therapies Inc

ITCI

Equity

ISIN US46116X1019 / Valor 23194616

NASDAQ (2024-11-21)

USD 85.45-0.22%

Intra-Cellular Therapies Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Intra-Cellular Therapies Inc is a biopharmaceutical company that focuses on developing therapies based on Dr. Paul Greengard's Nobel Prize-winning research on the inner workings of cells in the body. The company is led by experienced industry professionals and scientific advisors, aiming to bring innovative treatments to market for various medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

46.0%1Y

112%3Y

801%5Y

Performance

40.8%1Y

46.2%3Y

74.3%5Y

Volatility

9079 M

Market cap (USD)

134,778

Daily traded volume (Shares)

86.05 / 84.42

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Alignment Healthcare Inc

Alignment Healthcare Inc Valor: 110387702

Annual Return

-50%0%+50%

Risk level

110

1.26%USD 12.10

Emeis

Emeis Valor: 132546338

Annual Return

-50%0%+50%

Risk level

110

-6.89%EUR 5.21

SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA Valor: 128964250

Annual Return

-50%0%+50%

Risk level

110

-0.38%EUR 26.22

Sandoz Group Ltd

Sandoz Group Ltd Valor: 124359842

Annual Return

-50%0%+50%

Risk level

110

-0.55%CHF 39.65

Galderma Group Ltd

Galderma Group Ltd Valor: 133539272

Annual Return

-50%0%+50%

Risk level

110

-0.93%CHF 85.15

Curatis Holding Ltd

Curatis Holding Ltd Valor: 133078097

Annual Return

-50%0%+50%

Risk level

110

-6.33%CHF 14.05

Ardent Health Partners Inc

Ardent Health Partners Inc Valor: 136301364

Annual Return

-50%0%+50%

Risk level

110

-3.89%USD 15.80

Tempus AI Inc

Tempus AI Inc Valor: 135855934

Annual Return

-50%0%+50%

Risk level

110

-9.75%USD 52.48

Paul Hartmann AG

Paul Hartmann AG Valor: 1547181

Annual Return

-50%0%+50%

Risk level

110

0.94%EUR 214.00

Lineage Inc

Lineage Inc Valor: 136372357

Annual Return

-50%0%+50%

Risk level

110

-1.42%USD 62.95

Logos provided by Clearbit

Intra-Cellular Therapies Inc

ITCI

ISIN US46116X1019 / Valor 23194616

Intra-Cellular Therapies Inc UMushroom community rating:

Intra-Cellular Therapies Inc
UMushroom community rating: